Mathew Aby J.'s Form 4 filing
Biolife Solutions Inc (BLFS) · filed Sep 18, 2024
- Accession no.
- 0001628280-24-040832
- Filed
- Sep 18, 2024
- Trade date
- Jul 11-Sep 16, 2024
- Filing delay
- 69 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $17.9K. It was filed 69 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mathew Aby J.CIK 0001556355 | Officer (EVP & Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | Common Stock | SSaleDisposed | −313 | $20.54 | −$6,429.02 | 318,170 | Direct | |
| Aug 21, 2024 | Common Stock | SSaleDisposed | −111 | $25.61 | −$2,842.71 | 318,059 | Direct | |
| Sep 16, 2024 | Common Stock | SSaleDisposed | −343 | $25.12 | −$8,616.16 | 317,716 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.